Drugmaker Glenmark Pharmaceuticals launched
malaria treatment drug atovaquone and proguanil hydrochloride in the US.
Atovaquone and proguanil hydrochloride tablets are generic equivalent of
GlaxoSmithKline's brand Malarone.
The Indian drugmaker had settled a patent litigation with GlaxoSmithKline in April 2010, which allows Glenmark to launch the generic tablets in the US on royalty-bearing licence in the third quarter of calendar year 2011.
The Indian drugmaker had settled a patent litigation with GlaxoSmithKline in April 2010, which allows Glenmark to launch the generic tablets in the US on royalty-bearing licence in the third quarter of calendar year 2011.
No comments:
Post a Comment